INMB · Inmune Bio, Inc.
$2.17
+0.09 (+4.33%)
At close · Aug 14
Going-concern doubt
— flagged Aug 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Given the Company's projected operating requirements and its existing cash and cash equivalents, the Company is projecting insufficient liquidity to sustain its operations through one year following the date that the financial statements are issued. These conditions and events raise substantial doubt about the Company's ability to continue as a going concern. Because management's plans have not yet been finalized and are not within the Company's control, the implementation of such plans cannot be considered probable. As a result, the Company has concluded that management's plans do not alleviate substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 6, 2026
Market Cap
$60.23M
Shares
27.75M
Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.
Model estimate
Expected Aug 14 short interest
as of Aug 14
2,084,311
-5.4% vs reported
Short Squeeze Score
78/100
Short interest 7.9% of shares — P85
Days to cover 6.6 — P78
Price vs VWAP +32.3% — P97
Short-volume trend +7.2% — P77
Short interest change -7.6% — P33
Worst FTD 0.13% of shares — P80
Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-07-31). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
|
2026-08-31
Scheduled
FINRA publishes Sep 10
|
— | — | — | — |
|
2026-08-14
Scheduled
FINRA publishes Aug 25
|
— | — | — | — |
| 2026-07-31 | 2,203,321 | 2,384,123 | -180,802 | 6.64 |
| 2026-07-15 | 2,384,123 | 3,068,023 | -683,900 | 2.21 |
| 2026-06-30 | 3,068,023 | 3,668,941 | -600,918 | 1.62 |
| 2026-06-15 | 3,668,941 | 3,689,456 | -20,515 | 11.27 |
| 2026-05-29 | 3,689,456 | 3,641,628 | +47,828 | 14.38 |
| 2026-05-15 | 3,641,628 | 3,540,274 | +101,354 | 5.34 |
| 2026-04-30 | 3,540,274 | 3,369,296 | +170,978 | 17.79 |
| 2026-04-15 | 3,369,296 | 3,425,591 | -56,295 | 10.07 |
| 2026-03-31 | 3,425,591 | 3,256,235 | +169,356 | 6.99 |
| 2026-03-13 | 3,256,235 | 3,806,985 | -550,750 | 5.81 |
| 2026-02-27 | 3,806,985 | 3,964,097 | -157,112 | 7.65 |
| 2026-02-13 | 3,964,097 | 4,047,425 | -83,328 | 13.07 |
| 2026-01-30 | 4,047,425 | 3,896,241 | +151,184 | 13.06 |
| 2026-01-15 | 3,896,241 | 3,241,827 | +654,414 | 11.39 |
| 2025-12-31 | 3,241,827 | 3,419,054 | -177,227 | 8.74 |
| 2025-12-15 | 3,419,054 | 3,126,363 | +292,691 | 5.52 |
| 2025-11-28 | 3,126,363 | 3,449,639 | -323,276 | 7.71 |
| 2025-11-14 | 3,449,639 | 3,192,896 | +256,743 | 9.87 |
| 2025-10-31 | 3,192,896 | 3,476,629 | -283,733 | 9.62 |
| 2025-10-15 | 3,476,629 | 3,279,355 | +197,274 | 8.94 |
| 2025-09-30 | 3,279,355 | 3,325,709 | -46,354 | 6.62 |
| 2025-09-15 | 3,325,709 | 3,738,496 | -412,787 | 3.90 |
| 2025-08-29 | 3,738,496 | 5,330,331 | -1,591,835 | 4.50 |
Showing 1–23 of 23 settlements
Key facts
CIK
1711754
CUSIP
45782T105
13F (30d)
78 filings
78 filers
Visit website
Investor relations